
USFDA APPLICATION NUMBER - 201373 / DOSAGE - SUSPENSION;ORAL - 30MG/5ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| FEXOFENADINE HYDROCHLORIDE(UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) | FEXOFENADINE HYDROCHLORIDE | 30mg in 5 | 30mg in 5 |
Inactive Ingredients
| Ingredient Name | Actavis Pharma, Inc. | Cardinal Health, Inc. | Chain Drug Consortium, LLC | CVS Pharmacy | HEB | Kroger Company | Meijer Distribution Inc | Rite Aid | Rugby Laboratories | Supervalu Inc | Topco Associates LLC | Wal-Mart Stores Inc | Walgreen Company | Chattem, Inc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BUTYLPARABEN(3QPI1U3FV8) | ||||||||||||||
| EDETATE DISODIUM(7FLD91C86K) | ||||||||||||||
| POLOXAMER 407(TUF2IVW3M2) | ||||||||||||||
| POTASSIUM SORBATE(1VPU26JZZ4) | ||||||||||||||
| PROPYLENE GLYCOL(6DC9Q167V3) | ||||||||||||||
| PROPYLPARABEN(Z8IX2SC1OH) | ||||||||||||||
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS(22ADO53M6F) | ||||||||||||||
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE(70WT22SF4B) | ||||||||||||||
| SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS(KH7I04HPUU) | ||||||||||||||
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE(593YOG76RN) | ||||||||||||||
| SUCROSE(C151H8M554) | ||||||||||||||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||||||||||||||
| WATER(059QF0KO0R) | ||||||||||||||
| XANTHAN GUM(TTV12P4NEE) | ||||||||||||||
| XYLITOL(VCQ006KQ1E) |